CN Patent

CN1379668A — 3(5)－脲基－吡唑衍生物、其制备方法及其作为抗肿瘤剂的用途

Assigned to Pharmacia and Upjohn Co · Expires 2002-11-13 · 24y expired

What this patent protects

式(I)所示的3－脲基－吡唑衍生物或其可药用盐:其中R、R 1 和R 2 如文中所描述;该化合物可用于,例如,治疗癌症、细胞增殖性疾病、早老性痴呆、病毒感染、自身免疫疾病或神经变性疾病。

USPTO Abstract

式(I)所示的3－脲基－吡唑衍生物或其可药用盐:其中R、R 1 和R 2 如文中所描述;该化合物可用于,例如,治疗癌症、细胞增殖性疾病、早老性痴呆、病毒感染、自身免疫疾病或神经变性疾病。

Drugs covered by this patent

trilaciclib-dihydrochloride (TRILACICLIB DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN1379668A
Jurisdiction: CN
Classification: —
Expires: 2002-11-13
Drug substance claim: No
Drug product claim: No
Assignee: Pharmacia and Upjohn Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.